Bruker Announces Formation of New Bruker Spatial Biology Division
Bruker (Nasdaq: BRKR) has announced the formation of a new division, Bruker Spatial Biology, offering comprehensive solutions for spatial biology research. This division brings together NanoString Technologies, Canopy Biosciences, and Bruker Spatial Genomics (formerly Acuity Spatial Genomics).
The new division will focus on advancing biomedical research with a suite of spatial biology instruments, assays, software, data analytics, and CRO services. Its portfolio includes NanoString's GeoMx®, CosMx™, and AtoMx™, Canopy Biosciences' CellScape™, and NanoString's nCounter® for gene expression analysis.
Bruker Spatial Biology aims to provide tailored solutions for customers' unique spatial research needs, offering choices across the spectrum from discovery to translational research. The division will showcase its technologies at the Society for Immunotherapy of Cancer (SITC) 2024 from November 8-10 in Houston, Texas.
Bruker (Nasdaq: BRKR) ha annunciato la creazione di una nuova divisione, Bruker Spatial Biology, che offre soluzioni complete per la ricerca sulla biologia spaziale. Questa divisione riunisce NanoString Technologies, Canopy Biosciences e Bruker Spatial Genomics (ex Acuity Spatial Genomics).
La nuova divisione si concentrerà sull'avanzamento della ricerca biomedica con una gamma di strumenti, saggi, software, analisi dei dati e servizi CRO dedicati alla biologia spaziale. Il suo portafoglio include GeoMx® di NanoString, CosMx™, AtoMx™, CellScape™ di Canopy Biosciences e nCounter® di NanoString per l'analisi dell'espressione genica.
Bruker Spatial Biology punta a fornire soluzioni su misura per le uniche esigenze di ricerca spaziale dei clienti, offrendo scelte lungo l'intero spettro, dalla scoperta alla ricerca traslazionale. La divisione presenterà le sue tecnologie alla Society for Immunotherapy of Cancer (SITC) 2024, che si terrà a Houston, Texas, dall'8 al 10 novembre.
Bruker (Nasdaq: BRKR) ha anunciado la formación de una nueva división, Bruker Spatial Biology, que ofrece soluciones integrales para la investigación en biología espacial. Esta división reúne a NanoString Technologies, Canopy Biosciences y Bruker Spatial Genomics (anteriormente conocida como Acuity Spatial Genomics).
La nueva división se enfocará en avanzar la investigación biomédica con un conjunto de instrumentos, ensayos, software, análisis de datos y servicios CRO dedicados a la biología espacial. Su cartera incluye GeoMx® de NanoString, CosMx™, AtoMx™, CellScape™ de Canopy Biosciences y nCounter® de NanoString para análisis de expresión génica.
Bruker Spatial Biology tiene como objetivo proporcionar soluciones personalizadas para las necesidades únicas de investigación espacial de los clientes, ofreciendo opciones a lo largo del espectro, desde el descubrimiento hasta la investigación traslacional. La división presentará sus tecnologías en la Society for Immunotherapy of Cancer (SITC) 2024, que se llevará a cabo del 8 al 10 de noviembre en Houston, Texas.
브루커(나스닥: BRKR)는 브루커 공간 생물학이라는 새로운 부서를 설립했다고 발표했습니다. 이 부서는 공간 생물학 연구를 위한 종합 솔루션을 제공합니다. 이 부서에는 나노스트링 기술, 캐노피 바이오사이언스, 브루커 스페이셜 유전체학(구 아큐이티 스페이셜 유전체학)이 포함됩니다.
새로운 부서는 공간 생물학 기기, 분석, 소프트웨어, 데이터 분석 및 CRO 서비스를 갖춘 비판적 생물 의학 연구를 발전시키는 데 중점을 둘 것입니다. 포트폴리오에는 나노스트링의 GeoMx®, CosMx™, AtoMx™, 캐노피 바이오사이언스의 CellScape™, 그리고 나노스트링의 유전자 발현 분석을 위한 nCounter®가 포함됩니다.
브루커 공간 생물학은 고객의 독특한 공간 연구 요구에 맞춘 맞춤형 솔루션을 제공하는 것을 목표로 하며, 발견에서 변환 연구에 이르기까지 스펙트럼 전반에 걸쳐 선택 사항을 제공합니다. 이 부서는 2024년 11월 8일부터 10일까지 텍사스 주 휴스턴에서 열리는 암 면역치료 학회(SITC)에서 기술을 선보일 예정입니다.
Bruker (Nasdaq: BRKR) a annoncé la création d'une nouvelle division, Bruker Spatial Biology, qui propose des solutions complètes pour la recherche en biologie spatiale. Cette division regroupe NanoString Technologies, Canopy Biosciences et Bruker Spatial Genomics (anciennement Acuity Spatial Genomics).
La nouvelle division se concentrera sur l'avancement de la recherche biomédicale avec une gamme d'instruments, de tests, de logiciels, d'analyses de données et de services CRO dédiés à la biologie spatiale. Son portefeuille comprend GeoMx® de NanoString, CosMx™, AtoMx™, CellScape™ de Canopy Biosciences et nCounter® de NanoString pour l'analyse de l'expression génique.
Bruker Spatial Biology vise à fournir des solutions personnalisées pour les besoins uniques de recherche spatiale de ses clients, offrant des choix sur l'ensemble du spectre, de la découverte à la recherche translationnelle. La division présentera ses technologies à la Society for Immunotherapy of Cancer (SITC) 2024, qui se déroulera à Houston, Texas, du 8 au 10 novembre.
Bruker (Nasdaq: BRKR) hat die Gründung einer neuen Abteilung, Bruker Spatial Biology, bekannt gegeben, die umfassende Lösungen für die Forschung zur räumlichen Biologie bietet. Diese Abteilung vereint NanoString Technologies, Canopy Biosciences und Bruker Spatial Genomics (ehemals Acuity Spatial Genomics).
Die neue Abteilung wird sich darauf konzentrieren, die biomedizinische Forschung mit einer Reihe von Instrumenten, Assays, Software, Datenanalysen und CRO-Dienstleistungen zur räumlichen Biologie voranzutreiben. Zu ihrem Portfolio gehören NanoStrings GeoMx®, CosMx™, AtoMx™, Canopy Biosciences CellScape™ und NanoStrings nCounter® zur Analyse der Genexpression.
Bruker Spatial Biology zielt darauf ab, maßgeschneiderte Lösungen für die einzigartigen räumlichen Forschungsbedürfnisse der Kunden bereitzustellen und bietet eine Auswahl entlang des Spektrums von der Entdeckung bis zur Translation. Die Abteilung wird ihre Technologien bei der Society for Immunotherapy of Cancer (SITC) 2024 vom 8. bis 10. November in Houston, Texas, präsentieren.
- Formation of a new division, Bruker Spatial Biology, offering comprehensive spatial biology solutions
- Integration of NanoString Technologies, Canopy Biosciences, and Bruker Spatial Genomics under one operational coordination
- Diverse portfolio of spatial biology platforms addressing various research needs
- Ability to provide tailored solutions for customers' unique spatial research requirements
- None.
Bruker Spatial Biology Offers the Widest Range of Industry-leading Multiomic Spatial Biology Platforms to Scientists Globally
Bruker Spatial Biology will focus on elevating the industry’s most promising technologies for the advancement of biomedical research with a suite of spatial biology instruments, assays, software, data analytics, and CRO services. This uniquely positions Bruker’s new division with a comprehensive and cutting-edge spatial technology offering that includes NanoString’s GeoMx®, CosMx™, and AtoMx™ along with Canopy Biosciences’ CellScape™, all specifically designed to address distinct spatial biology research needs. NanoString’s nCounter® for gene expression analysis is also included in the portfolio along with Canopy’s Multi-Omic Services, which provides contract research services utilizing each of these platforms.
“The formation of Bruker Spatial Biology brings together the coordination of spatial platforms that are best-in-class across spatial genomics, transcriptomics, and proteomics,” said Mark R. Munch, PhD, President of the Bruker NANO group. “Bruker Spatial Genomics enables direct visualization of the 3D genome, which complements the recent additions of GeoMx and CosMx, cutting-edge highly sensitive and high-plex tools for the study of spatial transcriptomics at both regional and single cell resolution. Further rounding out our portfolio is CellScape, which enables targeted, quantitative spatial proteomics with best-in-class resolution and dynamic range.”
Todd Garland, the President of the new division, commented: “I am excited to lead Bruker Spatial Biology for the benefit of our global research customers. By bringing these diverse and complementary spatial platforms together, we can tailor solutions for each customer’s unique spatial research by providing choices across the entire spectrum from discovery to translational while avoiding compromises inherent with a ‘one-size-fits-all’ approach.”
Bruker Spatial Biology will be showcasing their technologies at the Society for Immunotherapy of Cancer (SITC) 2024 from November 8-10 in
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is at the forefront of the post-genomic era, helping scientists and engineers make groundbreaking discoveries that enhance human life. Our high-performance instruments and analytical solutions enable the exploration of life and materials at the molecular, cellular, and microscopic levels. Working closely with customers, we drive innovation, boost productivity, and support success in life sciences, biopharma, microscopy, nanoanalysis, industrial research, and next-gen semiconductor metrology for AI. Bruker provides highly differentiated, cutting-edge systems for preclinical imaging, clinical phenomics, proteomics, multiomics, spatial and single-cell biology, functional structural biology, clinical microbiology, and molecular diagnostics. For more information, please visit www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241011521950/en/
Investors:
Joe Kostka
Associate Director, Investor Relations
Bruker Corporation
T: +1-978-313-5800
E: Investor.Relations@bruker.com
Media:
Kevin Gamber
Vice President, Downstream Marketing
Bruker Spatial Biology
T: +1-314-662-9987
E: kevin.gamber@bruker.com
Source: Bruker Corporation
FAQ
What is the new division announced by Bruker (BRKR)?
What companies are included in the new Bruker Spatial Biology division?
What spatial biology platforms are offered by Bruker Spatial Biology?
Where will Bruker Spatial Biology showcase its technologies in 2024?
